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culture plates (Freundlich and Avdalovic, 1983). Purified monocytes In Response to Freed et al.
were then differentiated on tissue culture plates for 7-10 days and
infected as described (Kornbluth et al., 1989). Our recent proposal that the C-terminal tyrosine phos-
phorylation of MA reveals the karyophilic potential of
Cell Cycle Analyses
this protein within the contextof theHIV-1 preintegrationDNA content of nuclei was determined as described (Nicoletti et
complex relied on a series of experiments which helpedal., 1991) by lysing plasma membranes, staining nuclear DNA with
propidium iodide, and quantitating the relative DNA content of nuclei to define the components of this complex and to identify
using the Becton-Dickinson FACSORT fluorescence activated cell their interactions among each other and with the cell
sorter. The proportion of nuclei in G0/G1, S, and G2/M was deter- nuclear import machinery, and which examined their
mined using the MODFIT DNA analysis software. intracellular trafficking during the early steps of the viral
life cycle (Gallay et al., 1995a, 1995b). Using tyrosineIn Situ Hybridization
kinase inhibitors, Bukrinskaya et al. (1996) confirmedCells were fixed and hybridized overnight in hybridization buffer
that MA tyrosine phosphorylation promotes the nuclear(Bertholdand Maldarelli, 1996) to a 32P-labeled DNA probe generated
by random priming (multiprime DNA labeling kit, Amersham) from targeting of the viral DNA and facilitates HIV-1 infection
a 5.3 kb DNA fragment including the U5-gag/pol, vif, and a portion of nondividing cells, even though they suggested that
of the vpr region of HIV-1 (pNL4-3 nucleotides 433-5743). Cells the C-terminal residuemight not be thesole phosphotyr-
were washed as described (Berthold and Maldarelli), then air dried,
osine present in MA.subjected to autoradiography, examined by microscopy, andscored
Freed et al. previously questioned the role of the MAfor HIV-1 infection when signal was present within the nuclei.
NLS in HIV-1 infection of macrophages (Freed and Mar-
tin, 1994; Freed et al., 1995). In line with this position,Eric O. Freed, George Englund, Frank Maldarelli,
they now present data contesting the participation ofand Malcolm A. Martin
the C-terminal phosphorylation of MA in this process.Laboratory of Molecular Microbiology
To address this controversy, we first compared the sta-National Institute of Allergy and Infectious Diseases
tus of MA tyrosine phosphorylation of their and our vi-National Institutes of Health
ruses. We found that in both cases the C-terminal resi-Bethesda, MD 20892-0460
due was the only phosphotyrosine of MA, in agreement
with the results of our past analyses of a number of
References HIV-1 and HIV-2 strains. The replicative capacities of the
two sets of viruses were then measured in monocyte-
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some experimental conditions the point made by Freed
et al. is valid, we feel at this stage that technical differ-
ences, for instance related to the use of different m.o.i.'s,
explain the discrepancy between their and our results.
Additional studies examining the composition and the
processing of the HIV-1 preintegration complex should
put the issue to rest.
Didier Trono and Philippe Gallay
The Salk Institute for Biological Studies
10010 North Torrey Pines Road
La Jolla, CA 92037±1099
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